Literature DB >> 21266355

In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.

Diane Marotta1, Jayashree Karar, W Timothy Jenkins, Monika Kumanova, Kevin W Jenkins, John W Tobias, Donald Baldwin, Artemis Hatzigeorgiou, Panagiotis Alexiou, Sydney M Evans, Rodolfo Alarcon, Amit Maity, Cameron Koch, Constantinos Koumenis.   

Abstract

Hypoxia is a key determinant of tumor aggressiveness, yet little is known regarding hypoxic global gene regulation in vivo. We used the hypoxia marker EF5 coupled with laser-capture microdissection to isolate RNA from viable hypoxic and normoxic regions of 9L experimental gliomas. Through microarray analysis, we identified several mRNAs (including the HIF targets Vegf, Glut-1, and Hsp27) with increased levels under hypoxia compared with normoxia both in vitro and in vivo. However, we also found striking differences between the global in vitro and in vivo hypoxic mRNA profiles. Intriguingly, the mRNA levels of a substantial number of immunomodulatory and DNA repair proteins including CXCL9, CD3D, and RAD51 were found to be downregulated in hypoxic areas in vivo, consistent with a protumorigenic role of hypoxia in solid tumors. Immunohistochemical staining verified increased HSP27 and decreased RAD51 protein levels in hypoxic versus normoxic tumor regions. Moreover, CD8(+) T cells, which are recruited to tumors upon stimulation by CXCL9 and CXCL10, were largely excluded from viable hypoxic areas in vivo. This is the first study to analyze the influence of hypoxia on mRNA levels in vivo and can be readily adapted to obtain a comprehensive picture of hypoxic regulation of gene expression and its influence on biological functions in solid tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266355      PMCID: PMC3071295          DOI: 10.1158/0008-5472.CAN-10-3061

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

2.  The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi.

Authors:  Jenny L Hardison; Ruth A Wrightsman; Philip M Carpenter; Thomas E Lane; Jerry E Manning
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Importance of antibody concentration in the assessment of cellular hypoxia by flow cytometry: EF5 and pimonidazole.

Authors:  Cameron J Koch
Journal:  Radiat Res       Date:  2008-06       Impact factor: 2.841

4.  Lysyl oxidase is essential for hypoxia-induced metastasis.

Authors:  Janine T Erler; Kevin L Bennewith; Monica Nicolau; Nadja Dornhöfer; Christina Kong; Quynh-Thu Le; Jen-Tsan Ashley Chi; Stefanie S Jeffrey; Amato J Giaccia
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

5.  Hypoxic inhibition of 3-methylcholanthrene-induced CYP1A1 expression is independent of HIF-1alpha.

Authors:  Jared W Allen; Randall S Johnson; Sangeeta N Bhatia
Journal:  Toxicol Lett       Date:  2005-01-15       Impact factor: 4.372

6.  Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts.

Authors:  N N Khodarev; J O Park; J Yu; N Gupta; E Nodzenski; B Roizman; R R Weichselbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

7.  Endogenous hypoxia markers: case not proven!

Authors:  Arnulf Mayer; Michael Höckel; Peter Vaupel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 8.  Investigating hypoxic tumor physiology through gene expression patterns.

Authors:  Nicholas C Denko; Lucrezia A Fontana; Karen M Hudson; Patrick D Sutphin; Soumya Raychaudhuri; Russ Altman; Amato J Giaccia
Journal:  Oncogene       Date:  2003-09-01       Impact factor: 9.867

9.  2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.

Authors:  S M Evans; W T Jenkins; B Joiner; E M Lord; C J Koch
Journal:  Cancer Res       Date:  1996-01-15       Impact factor: 12.701

10.  Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer.

Authors:  J J Ord; E H Streeter; I S D Roberts; D Cranston; A L Harris
Journal:  Br J Cancer       Date:  2005-08-08       Impact factor: 7.640

View more
  25 in total

1.  Cyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics.

Authors:  Atsushi Fujimura; Hiroyuki Michiue; Yan Cheng; Atsuhito Uneda; Yasunari Tani; Tei-ichi Nishiki; Tomotsugu Ichikawa; Fan-Yan Wei; Kazuhito Tomizawa; Hideki Matsui
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

2.  Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.

Authors:  Kanstantsin V Katlinski; Jun Gui; Yuliya V Katlinskaya; Angelíca Ortiz; Riddhita Chakraborty; Sabyasachi Bhattacharya; Christopher J Carbone; Daniel P Beiting; Melanie A Girondo; Amy R Peck; Ellen Puré; Priya Chatterji; Anil K Rustgi; J Alan Diehl; Constantinos Koumenis; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2017-02-13       Impact factor: 31.743

3.  Molecular Characterization of Hypoxic Alveolar Epithelial Cells After Lung Contusion Indicates an Important Role for HIF-1α.

Authors:  Matthew A Sherman; Madathilparambil V Suresh; Vladislav A Dolgachev; Lane K McCandless; Xiang Xue; Li Ziru; David Machado-Aranda; Yatrik M Shah; Krishnan Raghavendran
Journal:  Ann Surg       Date:  2018-02       Impact factor: 12.969

Review 4.  Targeting hypoxia in cancer therapy.

Authors:  William R Wilson; Michael P Hay
Journal:  Nat Rev Cancer       Date:  2011-06       Impact factor: 60.716

5.  Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs.

Authors:  Xiaohu Tang; Joseph E Lucas; Julia Ling-Yu Chen; Gregory LaMonte; Jianli Wu; Michael Changsheng Wang; Constantinos Koumenis; Jen-Tsan Chi
Journal:  Cancer Res       Date:  2011-12-01       Impact factor: 12.701

6.  Androgen withdrawal fails to induce detectable tissue hypoxia in the rat prostate.

Authors:  Sietze Regter; Mohammad Hedayati; Yonggang Zhang; Haoming Zhou; Susan Dalrymple; Cameron J Koch; John T Isaacs; Theodore L DeWeese
Journal:  Prostate       Date:  2014-03-27       Impact factor: 4.104

7.  Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.

Authors:  Paulina Kucharzewska; Helena C Christianson; Johanna E Welch; Katrin J Svensson; Erik Fredlund; Markus Ringnér; Matthias Mörgelin; Erika Bourseau-Guilmain; Johan Bengzon; Mattias Belting
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

8.  Clinically relevant biomarkers in targeted radiotherapy.

Authors:  Baldassarre Stea; John Gordon
Journal:  Clin Exp Metastasis       Date:  2012-08-11       Impact factor: 5.150

Review 9.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

10.  Hypoxia-induced alterations of G2 checkpoint regulators.

Authors:  Grete Hasvold; Christin Lund-Andersen; Malin Lando; Sebastian Patzke; Sissel Hauge; ZhenHe Suo; Heidi Lyng; Randi G Syljuåsen
Journal:  Mol Oncol       Date:  2016-01-08       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.